These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 7752142)

  • 1. Serum markers of systemic disease processes in osteoarthritis.
    Thonar EJ; Masuda K; Lenz ME; Hauselmann HJ; Kuettner KE; Manicourt DH
    J Rheumatol Suppl; 1995 Feb; 43():68-70. PubMed ID: 7752142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The release of aggrecan fragments into synovial fluid after joint injury and in osteoarthritis.
    Lohmander LS
    J Rheumatol Suppl; 1995 Feb; 43():75-7. PubMed ID: 7752145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential levels of synovial fluid aggrecan aggregate components in experimental osteoarthritis and joint disuse.
    Ratcliffe A; Beauvais PJ; Saed-Nejad F
    J Orthop Res; 1994 Jul; 12(4):464-73. PubMed ID: 7520485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in joint cartilage aggrecan after knee injury and in osteoarthritis.
    Lohmander LS; Ionescu M; Jugessur H; Poole AR
    Arthritis Rheum; 1999 Mar; 42(3):534-44. PubMed ID: 10088777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synovial fluid levels of tumor necrosis factor alpha and oncostatin M correlate with levels of markers of the degradation of crosslinked collagen and cartilage aggrecan in rheumatoid arthritis but not in osteoarthritis.
    Manicourt DH; Poilvache P; Van Egeren A; Devogelaer JP; Lenz ME; Thonar EJ
    Arthritis Rheum; 2000 Feb; 43(2):281-8. PubMed ID: 10693867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Turnover of type II collagen and aggrecan in cartilage matrix at the onset of inflammatory arthritis in humans: relationship to mediators of systemic and local inflammation.
    Fraser A; Fearon U; Billinghurst RC; Ionescu M; Reece R; Barwick T; Emery P; Poole AR; Veale DJ
    Arthritis Rheum; 2003 Nov; 48(11):3085-95. PubMed ID: 14613270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum and synovial fluid concentrations of keratan sulfate and hyaluronan in dogs with induced stifle joint osteoarthritis following cranial cruciate ligament transection.
    Budsberg SC; Lenz ME; Thonar EJ
    Am J Vet Res; 2006 Mar; 67(3):429-32. PubMed ID: 16506904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment with calcitonin suppresses the responses of bone, cartilage, and synovium in the early stages of canine experimental osteoarthritis and significantly reduces the severity of the cartilage lesions.
    Manicourt DH; Altman RD; Williams JM; Devogelaer JP; Druetz-Van Egeren A; Lenz ME; Pietryla D; Thonar EJ
    Arthritis Rheum; 1999 Jun; 42(6):1159-67. PubMed ID: 10366108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topographic variation in biglycan and decorin synthesis by articular cartilage in the early stages of osteoarthritis: an experimental study in sheep.
    Little CB; Ghosh P; Bellenger CR
    J Orthop Res; 1996 May; 14(3):433-44. PubMed ID: 8676257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating keratan sulfate: a marker of cartilage proteoglycan catabolism in osteoarthritis.
    Thonar EJ; Manicourt DM; Williams J; Lenz ME; Sweet MB; Schnitzer TJ; Otten L; Glant T; Kuettner KE
    J Rheumatol Suppl; 1991 Feb; 27():24-6. PubMed ID: 2027120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies of the articular cartilage proteoglycan aggrecan in health and osteoarthritis. Evidence for molecular heterogeneity and extensive molecular changes in disease.
    Rizkalla G; Reiner A; Bogoch E; Poole AR
    J Clin Invest; 1992 Dec; 90(6):2268-77. PubMed ID: 1281828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repeated intraarticular injections of triamcinolone acetonide alter cartilage matrix metabolism measured by biomarkers in synovial fluid.
    Céleste C; Ionescu M; Robin Poole A; Laverty S
    J Orthop Res; 2005 May; 23(3):602-10. PubMed ID: 15885481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of cartilage biomarkers in the early phases of canine experimental osteoarthritis.
    Matyas JR; Atley L; Ionescu M; Eyre DR; Poole AR
    Arthritis Rheum; 2004 Feb; 50(2):543-52. PubMed ID: 14872497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid and sustained rise in the serum level of hyaluronan after anterior cruciate ligament transection in the dog knee joint.
    Manicourt DH; Cornu O; Lenz ME; Druetz-van Egeren A; Thonar EJ
    J Rheumatol; 1995 Feb; 22(2):262-9. PubMed ID: 7738949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The early molecular natural history of experimental osteoarthritis. I. Progressive discoordinate expression of aggrecan and type II procollagen messenger RNA in the articular cartilage of adult animals.
    Matyas JR; Ehlers PF; Huang D; Adams ME
    Arthritis Rheum; 1999 May; 42(5):993-1002. PubMed ID: 10323456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spontaneous and experimental osteoarthritis in dog: similarities and differences in proteoglycan levels.
    Liu W; Burton-Wurster N; Glant TT; Tashman S; Sumner DR; Kamath RV; Lust G; Kimura JH; Cs-Szabo G
    J Orthop Res; 2003 Jul; 21(4):730-7. PubMed ID: 12798075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of synovial fluid markers of cartilage synthesis and turnover to study effects of repeated intra-articular administration of methylprednisolone acetate on articular cartilage in vivo.
    Robion FC; Doizé B; Bouré L; Marcoux M; Ionescu M; Reiner A; Poole AR; Laverty S
    J Orthop Res; 2001 Mar; 19(2):250-8. PubMed ID: 11347698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regional quantification of cartilage type II collagen and aggrecan messenger RNA in joints with early experimental osteoarthritis.
    Matyas JR; Huang D; Chung M; Adams ME
    Arthritis Rheum; 2002 Jun; 46(6):1536-43. PubMed ID: 12115184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aggrecan degradation in osteoarthritis and rheumatoid arthritis.
    Lark MW; Bayne EK; Lohmander LS
    Acta Orthop Scand Suppl; 1995 Oct; 266():92-7. PubMed ID: 8553869
    [No Abstract]   [Full Text] [Related]  

  • 20. Keratan sulfate in body fluids in joint disease.
    Thonar EJ; Masuda K; Häuselmann HJ; Uebelhart D; Lenz ME; Manicourt DH
    Acta Orthop Scand Suppl; 1995 Oct; 266():103-6. PubMed ID: 8553836
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.